Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 0 | 4.961.654 | 529.188 | 1 | ||
2010 | 0 | 17.918.818 | 988.703 | 2 |
Total number of partners: 2416
Partner loyalty:
Frequent Partner: (> 2 projects): 783
Rare Partner: 1633
Frequent / Rare Partner Ratio: 0.48
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-03-01 | Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector | GENEGRAFT | participant | 4.961.654 | 10 |
2010-01-01 | Fatty liver: Inhibition of Progression | FLIP | participant | 5.983.478 | 17 |
2010-01-01 | Regenerating Bone defects using New biomedical Engineering approaches | REBORNE | participant | 11.935.340 | 24 |